These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38536978)

  • 21. Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report.
    Torres EA; Chang Y; Desai S; Chang I; Zuckerman JE; Burwick R; Kalantar-Zadeh K; Hanna RM
    Case Rep Nephrol Dial; 2021; 11(1):95-102. PubMed ID: 33977097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K; Seeman T
    Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment.
    Medeni SS; Namdaroglu S; Cetintepe T; Ozlu C; Tasli F; Adibelli ZH; Bilgir O; Tatar E
    Hematol Rep; 2018 Sep; 10(3):7553. PubMed ID: 30344987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
    J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.
    Cugno M; Gualtierotti R; Possenti I; Testa S; Tel F; Griffini S; Grovetti E; Tedeschi S; Salardi S; Cresseri D; Messa P; Ardissino G
    J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Life-Threatening Extrarenal Manifestations in an Infant with Atypical Hemolytic Uremic Syndrome Caused by a Complement 3-Gene Mutation.
    Han SR; Cho MH; Moon JS; Ha IS; Cheong HI; Kang HG
    Kidney Blood Press Res; 2019; 44(5):1300-1305. PubMed ID: 31522186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
    Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
    Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Thajudeen B; Sussman A; Bracamonte E
    Case Rep Nephrol Urol; 2013 Jul; 3(2):139-46. PubMed ID: 24570684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
    Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
    Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S; Pradhan M; Meyers KE; Le Palma K; Laskin BL
    Clin Nephrol; 2015 Sep; 84(3):181-5. PubMed ID: 25816809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Rare Case of Atypical Hemolytic Uremia Syndrome Triggered by Influenza Vaccination.
    Kumar S; Bhagia G; Kaae J
    Cureus; 2022 Mar; 14(3):e23577. PubMed ID: 35494971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report.
    Fontana F; Alfano G; Bardhushi E; Ligabue G; Giovanella S; Neri I; Cappelli G
    Am J Case Rep; 2019 Oct; 20():1460-1465. PubMed ID: 31582717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.
    Gupta M; Govindappagari S; Burwick RM
    Obstet Gynecol; 2020 Jan; 135(1):46-58. PubMed ID: 31809447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.
    Claes KJ; Geerts I; Lemahieu W; Wilmer A; Kuypers DRJ; Koshy P; Ombelet S
    Am J Kidney Dis; 2023 Mar; 81(3):364-367. PubMed ID: 36342000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.
    Shen YM
    Thromb J; 2016; 14(Suppl 1):19. PubMed ID: 27766045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy-Associated Atypical Hemolytic Uremic Syndrome and Life-Long Kidney Failure.
    Mirza M; Sadiq N; Aye C
    Cureus; 2022 Jun; 14(6):e25655. PubMed ID: 35800199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Cavero T; Arjona E; Soto K; Caravaca-Fontán F; Rabasco C; Bravo L; de la Cerda F; Martín N; Blasco M; Ávila A; Huerta A; Cabello V; Jarque A; Alcázar C; Fulladosa X; Carbayo J; Anaya S; Cobelo C; Ramos N; Iglesias E; Baltar J; Martínez-Gallardo R; Pérez L; Morales E; González R; Macía M; Draibe J; Pallardó L; Quintana LF; Espinosa M; Barros X; Pereira F; Cao M; Moreno JA; Rodríguez de Córdoba S; Praga M;
    Kidney Int; 2019 Oct; 96(4):995-1004. PubMed ID: 31420192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome.
    Santos MS; Ventura S; Alves A; Cabral R; Henriques M
    Cureus; 2022 Jun; 14(6):e25743. PubMed ID: 35812637
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.